Combined approach in ventricular septal defect and adult pulmonary hypertension

Faruk Cingoz1, Murat Tavlasoglu, Mehmet Ali Sahin

  • 1Department of Cardiovascular Surgery, Gulhane Military Medical Academy, Ankara, Turkey.

Insights

Early closure of large ventricular septal defects is crucial. This case study shows successful pulmonary hypertension treatment in an adult after VSD closure using inhaled nitric oxide, sildenafil, and bosentan.

Area of Science:

  • Cardiology
  • Pulmonology
  • Adult Congenital Heart Disease

Background:

  • Early closure of large ventricular septal defects (VSDs) is critical to prevent elevated pulmonary vascular resistance.
  • Pulmonary hypertension can lead to significant morbidity and mortality, even after late VSD closure.

Observation:

  • A 25-year-old woman presented with pulmonary hypertension following the surgical closure of a large VSD.
  • The patient's condition required intensive management to address the post-surgical pulmonary hypertensive event.

Findings:

  • Successful treatment of severe pulmonary hypertension was achieved using a combination of inhaled nitric oxide, sildenafil, and bosentan.
  • This multi-drug approach effectively managed the pulmonary hypertensive crisis in the adult patient.

Implications:

  • Post-operative pulmonary hypertension management is a key factor influencing prognosis in adult VSD closure patients.
  • This case highlights the potential efficacy of inhaled nitric oxide, sildenafil, and bosentan in treating refractory pulmonary hypertension after VSD repair.

Related Concept Videos

Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
906
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
535
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
753
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
686
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
598
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
615